A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
An Open-label Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
Sponsor: Bristol-Myers Squibb
No open prediction endpoints
Endpoints are classified and published by ProgramSignal analysts.
Request endpoint coverageKey Facts
Primary Endpoints (CT.gov)
Taste Evaluation - Aromatic Identity
Time frame: Up to 3 Months
Taste Evaluation - Amplitude
Time frame: Up to 3 Months
Taste Evaluation - Mouthfeel
Time frame: Up to 3 Months
Taste Evaluation - Off-notes
Time frame: Up to 3 Months
Eligibility Criteria
Inclusion Criteria: * Participant is qualified based on training and experience. * Participants must be trained to detect, identify, recognize, and accurately describe different taste elements and flavor combinations. Training is initially accomplished by tasting model compounds and learning to recognize and describe these accurately. These abilities are then honed and refined through additional experience in performing taste profiling. * Participant is qualified based on training and experience. * Senopsys LLC will provide all participants. * Participants must be trained to detect, identify, recognize, and accurately describe different taste elements and flavor combinations. Training is initially accomplished by tasting model compounds and learning to recognize and describe these accurately. These abilities are then honed and refined through additional experience in performing taste profiling. Exclusion Criteria: * Participant has any history of any illness, medical condition, labo…
Read full criteria on CT.gov →✦ Analyst Commentary
Expert commentary on why this trial matters and what to watch for.
Request coverage →